The latest closing stock price for Rein Therapeutics as of February 21, 2025 is 2.70.
An investor who bought $1,000 worth of Rein Therapeutics stock at the IPO in 2017 would have $-988 today, roughly -1 times their original investment - a -42.18% compound annual growth rate over 8 years.
The all-time high Rein Therapeutics stock closing price was 298.20 on October 04, 2017.
The Rein Therapeutics 52-week high stock price is 7.42, which is 174.8% above the current share price.
The Rein Therapeutics 52-week low stock price is 1.61, which is 40.4% below the current share price.
The average Rein Therapeutics stock price for the last 52 weeks is 3.33.
An investor who bought $1,000 worth of Rein Therapeutics stock at the IPO in 2017 would have $-988 today, roughly -1 times their original investment - a -42.18% compound annual growth rate over 8 years.
The all-time high Rein Therapeutics stock closing price was 298.20 on October 04, 2017.
The Rein Therapeutics 52-week high stock price is 7.42, which is 174.8% above the current share price.
The Rein Therapeutics 52-week low stock price is 1.61, which is 40.4% below the current share price.
The average Rein Therapeutics stock price for the last 52 weeks is 3.33.